Therapeutic Effects of Robotic Exoskeleton-Assisted Gait Re-habilitation and Predictive Factors of Significant Improvements in Stroke Patients
Stroke Sequelae
About this trial
This is an interventional treatment trial for Stroke Sequelae focused on measuring robotic rehabilitation, stroke, quality of life, walking speed
Eligibility Criteria
Inclusion Criteria: patients aged from 30 to 80 years hemiparesis due to ischemic or hemorrhagic stroke in the last 6 months Exclusion Criteria: with a significant history of pain or injury of lower limbs that affected their walking ability, with cardiopulmonary diseases that prohibited exercise training with impaired cognitive function unable to complete the timed up-and-go test able to complete the timed up-and-go test in <20 seconds using walking device
Sites / Locations
- Taichung Veterans General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Robotic group
Control group
This group receives conventional rehabilitation plus robotic exoskeleton-assisted gait rehabilitation.
This group receives conventional rehabilitation alone.